Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Canopy Growth Corporation (CGC)

    Price:

    1.45 USD

    ( + 0.06 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    CGC
    Name
    Canopy Growth Corporation
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare
    Price
    1.450
    Market Cap
    347.686M
    Enterprise value
    331.112M
    Currency
    USD
    Ceo
    Luc Mongeau
    Full Time Employees
    1029
    Ipo Date
    2014-04-07
    City
    Smiths Falls
    Address
    1 Hershey Drive

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Viatris Inc.

    VALUE SCORE:

    6

    Symbol
    VTRS
    Market Cap
    11.801B
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare

    2nd position

    Amphastar Pharmaceuticals, Inc.

    VALUE SCORE:

    11

    Symbol
    AMPH
    Market Cap
    1.207B
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare

    The best

    Lantheus Holdings, Inc.

    VALUE SCORE:

    11

    Symbol
    LNTH
    Market Cap
    3.541B
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -0.750
    P/S
    1.494
    P/B
    0.786
    Debt/Equity
    0.670
    EV/FCF
    -4.599
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    2.228
    Earnings yield
    -1.334
    Debt/assets
    0.362
    FUNDAMENTALS
    Net debt/ebidta
    -0.491
    Interest coverage
    -1.752
    Research And Developement To Revenue
    0
    Intangile to total assets
    0.146
    Capex to operating cash flow
    -0.071
    Capex to revenue
    0.032
    Capex to depreciation
    0.212
    Return on tangible assets
    -0.663
    Debt to market cap
    0.798
    Piotroski Score
    4.000
    FUNDAMENTALS
    PEG
    -0.022
    P/CF
    -3.066
    P/FCF
    -3.657
    RoA %
    -56.478
    RoIC %
    -13.447
    Gross Profit Margin %
    20.592
    Quick Ratio
    2.124
    Current Ratio
    3.075
    Net Profit Margin %
    -186.874
    Net-Net
    -0.996
    FUNDAMENTALS PER SHARE
    FCF per share
    -0.707
    Revenue per share
    1.460
    Net income per share
    -2.721
    Operating cash flow per share
    -0.660
    Free cash flow per share
    -0.707
    Cash per share
    0.763
    Book value per share
    2.596
    Tangible book value per share
    1.897
    Shareholders equity per share
    2.596
    Interest debt per share
    2.076
    TECHNICAL
    52 weeks high
    5.800
    52 weeks low
    0.770
    Current trading session High
    1.515
    Current trading session Low
    1.380
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    DESCRIPTION

    Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

    NEWS
    https://images.financialmodelingprep.com/news/jp-brand-advisors-and-canopy-usa-form-strategic-partnership-20251007.jpg
    JP Brand Advisors and Canopy USA Form Strategic Partnership to Expand Hemp Beverage Distribution

    prnewswire.com

    2025-10-07 08:01:00

    DALLAS , Oct. 7, 2025 /PRNewswire/ -- JP Brand Advisors ("JPBA"), the leading outsourced sales and strategy partner for beverage alcohol and emerging functional beverage brands, and Canopy USA, LLC ("Canopy USA"), a brand-driven organization strategically positioned across the U.S. cannabis market, today announced a strategic partnership to expand the distribution of Wana Wellness, LLC ("Wana")'s hemp-based beverages and gummies in the United States. The partnership underscores JPBA's expanding focus on hemp-based functional beverages, a category generating significant attention across the beverage alcohol industry as consumer demand for wellness-driven innovation accelerates.

    https://images.financialmodelingprep.com/news/prediction-president-trump-will-legalize-marijuana-in-2026-20251005.jpg
    Prediction: President Trump Will Legalize Marijuana in 2026

    fool.com

    2025-10-05 15:23:00

    In case you haven't heard, President Donald Trump just gave his "strongest signal yet that movement on cannabis policy may be imminent" and that the federal government may be ready to finally legalize marijuana use in the U.S.

    https://images.financialmodelingprep.com/news/trumps-cbd-video-sparks-buzz-3-cannabis-stocks-to-20251003.jpg
    Trump's CBD Video Sparks Buzz: 3 Cannabis Stocks to Watch

    zacks.com

    2025-10-03 09:41:12

    Trump's CBD video fuels momentum in cannabis, with Village Farms, Canopy Growth, and Tilray emerging as stocks to watch in 2025.

    https://images.financialmodelingprep.com/news/canopy-growth-corporation-cgc-stock-slides-as-market-rises-20251002.jpg
    Canopy Growth Corporation (CGC) Stock Slides as Market Rises: Facts to Know Before You Trade

    zacks.com

    2025-10-02 19:01:10

    Canopy Growth Corporation (CGC) closed the most recent trading day at $1.36, moving 1.45% from the previous trading session.

    https://images.financialmodelingprep.com/news/canopy-growth-corporation-cgc-is-attracting-investor-attention-here-20251001.jpg
    Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know

    zacks.com

    2025-10-01 10:01:27

    Canopy Growth (CGC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

    https://images.financialmodelingprep.com/news/best-canadian-cannabis-stocks-to-watch-for-growth-and-20250930.jpg
    Best Canadian Cannabis Stocks to Watch for Growth and Opportunity

    marijuanastocks.com

    2025-09-30 10:00:10

    The U.S. cannabis industry has expanded rapidly, now generating over $33 billion in annual sales. Analysts project the market could exceed $56 billion by 2030. These figures highlight the growing opportunities for Canadian cannabis companies to target U.S. partnerships and eventual federal legalization. Recently, U.S. lawmakers renewed discussions about rescheduling cannabis under federal law. This sparked optimism and short-term volatility across cannabis stocks. Canadian firms remain positioned to benefit from regulatory progress and expanding cross-border demand. Their strategies include scaling production, diversifying product lines, and investing in branded distribution. As the industry evolves rapidly, investors must closely monitor these developments.

    https://images.financialmodelingprep.com/news/wall-street-breakfast-podcast-weed-stocks-light-up-20250930.jpg
    Wall Street Breakfast Podcast: Weed Stocks Light Up

    seekingalpha.com

    2025-09-30 07:04:30

    Cannabis stocks surged after Trump endorsed CBD for senior healthcare, citing its potential to revolutionize treatment and reduce healthcare costs. Shares of TLRY, CGC, CRON, and ACB soared double digits, with related ETFs MSOS and MJ also posting significant gains.

    https://images.financialmodelingprep.com/news/cannabis-stocks-soar-after-trump-shares-video-promoting-drugs-20250929.jpg
    Cannabis stocks soar after Trump shares video promoting drug's use for seniors

    theguardian.com

    2025-09-29 14:26:04

    Video posted on Truth Social touts CBD as a ‘gamechanger' and promotes Medicaid coverage of CBD products

    https://images.financialmodelingprep.com/news/cannabis-stocks-surge-after-trump-posts-video-touting-medicare-coverage-20250929.jpg
    Cannabis stocks surge after Trump posts video touting Medicare coverage for CBD

    nypost.com

    2025-09-29 12:41:49

    Tilray Brands surged nearly 20% and was up 36% after market open, while Canopy Growth jumped about 20% and Cronos Group rose 13%.

    https://images.financialmodelingprep.com/news/us-cannabis-stocks-soar-20-after-trump-endorses-cbds-20250929.jpg
    US cannabis stocks soar 20% after Trump endorses CBD's benefits for seniors

    invezz.com

    2025-09-29 06:43:07

    Following a social media post by US President Donald Trump over the weekend, which suggested potential health benefits from cannabidiol use, shares of cannabis companies rose in early premarket trading on Monday, according to a Reuters report.

    https://images.financialmodelingprep.com/news/canopy-growth-corporation-cgc-stock-drops-despite-market-gains-20250926.jpg
    Canopy Growth Corporation (CGC) Stock Drops Despite Market Gains: Important Facts to Note

    zacks.com

    2025-09-26 18:50:58

    Canopy Growth Corporation (CGC) concluded the recent trading session at $1.34, signifying a -2.19% move from its prior day's close.

    https://images.financialmodelingprep.com/news/canopy-growth-corporation-announces-adjournment-of-annual-general-and-20250926.jpg
    Canopy Growth Corporation Announces Adjournment of Annual General and Special Meeting of Shareholders Due to Lack of Quorum

    businesswire.com

    2025-09-26 14:00:00

    SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED) (NASDAQ:CGC) today announced that, due to the requisite quorum not being present, the annual general and special meeting of shareholders (the “Meeting”) scheduled for September 26, 2025 at 1:00 p.m. Eastern Time via live webcast was convened and then adjourned. The Meeting has been adjourned until October 10 at 1:00 PM ET and will be held via live audio webcast at www.virtualsharehold.

    https://images.financialmodelingprep.com/news/canopy-growth-announces-extension-of-proxy-voting-deadline-for-20250924.jpg
    Canopy Growth Announces Extension of Proxy Voting Deadline for Upcoming Annual General and Special Meeting

    businesswire.com

    2025-09-24 07:00:00

    SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED) (NASDAQ:CGC) announced today that it has extended the deadline for the submission of proxies related to its upcoming annual general and special meeting of shareholders (the “Meeting”) to September 26, 2025 at 9:00 AM ET. The Meeting will be held later the same day, at 1:00 PM ET via live audio webcast at www.virtualshareholdermeeting.com/WEED2025. The deadline is being extended to all.

    https://images.financialmodelingprep.com/news/canopy-growth-corporation-cgc-stock-drops-despite-market-gains-20250922.jpg
    Canopy Growth Corporation (CGC) Stock Drops Despite Market Gains: Important Facts to Note

    zacks.com

    2025-09-22 19:01:11

    In the closing of the recent trading day, Canopy Growth Corporation (CGC) stood at $1.32, denoting a -3.65% move from the preceding trading day.

    https://images.financialmodelingprep.com/news/canopy-growth-urges-shareholders-to-cast-their-vote-for-20250919.jpg
    Canopy Growth Urges Shareholders to Cast their Vote for the Upcoming Annual General and Special Meeting Today

    businesswire.com

    2025-09-19 07:00:00

    SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) today urges its shareholders to vote ahead of the upcoming annual general and special meeting of shareholders (the “Meeting”) on September 26, 2025 at 1:00 PM ET. Canopy Needs Your Vote – Vote Today and Help Us Reach Quorum Canopy Growth is approaching number of shares needed to reach quorum for the Meeting and needs your help to reach this threshold to avoid delaying the.

    https://images.financialmodelingprep.com/news/canopy-growth-corporation-cgc-is-a-trending-stock-facts-20250917.jpg
    Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It

    zacks.com

    2025-09-17 10:00:38

    Canopy Growth (CGC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.